- Fujifilm Corp. to manufacture Novavax Inc.’s COVID-19 vaccine candidate.
- Both companies agreed to manufacture bulk drug substance for the vaccine candidate.
- Novavax has been developing NVX-CoV2373, a vaccine for COVID-19.
- A pivotal phase 3 clinical trial of up to 30,000 subjects is under the way.
On Friday, Fujifilm Corp mentioned that its biotechnology subsidiary and U.S. vaccin....
Tags : JAPAN, FUJIFILM, BIOTECHNOLOGY, U.S.A NOVAVOX INC., COVID-19 VACCINE CANDIDATE,